Blends · Research Peptide

Wolverine

Synergistic Dual-Peptide Regenerative Stack

What is Wolverine?

The Wolverine blend is a pre-mixed research formulation that combines two peptides — BPC-157 and TB-500 — in a single lyophilized preparation. The rationale, drawn from preclinical literature, is that the two compounds engage complementary rather than overlapping pathways: BPC-157 (a 15-amino-acid pentadecapeptide, ~1,419.56 Da) is studied for VEGFR2-mediated angiogenesis and growth-factor signaling, while TB-500 (an actin-binding fragment of Thymosin Beta-4, ~887.0 Da) is studied for regulating actin polymerization and cell migration. Pairing an angiogenic-signaling peptide with a cytoskeletal, migration-oriented peptide is the conceptual basis researchers cite for investigating the two together in tissue-repair models.

Because Wolverine is a combination product, it carries the mechanistic profile of both constituents rather than introducing a novel one. Animal and cell studies of the individual peptides describe activity across tendon, ligament, muscle, bone, and gastrointestinal tissue for BPC-157, and cell-migration, angiogenic, and anti-inflammatory activity for TB-500. Any notion of "synergy" between them is a research hypothesis based on the complementarity of these pathways; it has not been established in controlled human studies, and combining two compounds also compounds the uncertainty around each.

The evidence caveat is therefore doubled here. Neither BPC-157 nor TB-500 has completed, controlled human efficacy trials, so the blend as a whole rests on preclinical data that may not translate to humans. Neither component is approved for human use by any regulatory authority, and both are prohibited in sport under anti-doping rules. The Wolverine blend is offered strictly for research and educational purposes only and is not intended for human consumption.

Molecular data

BPC-157: 1,419.56 Da · TB-500: 887.0 Da
Mol. Weight
≥99%
Purity
Lyophilized powder
Form
$49.00
Price
Amino acid sequence: BPC-157: GEPPPGKPADDAGLV · TB-500: Ac-LKKTETQ

Mechanism of action

In preclinical research, Wolverine is associated with the following pathways and targets:

BPC-157TB-500Dual RecoverySynergistic

Research highlights

  • Combines BPC-157 angiogenic signaling with TB-500 actin regulation
  • Synergistic dual-mechanism approach to tissue repair research
  • Pre-mixed for research convenience at validated ratios
  • Most popular recovery blend in the Purgo Labs catalog

Frequently asked questions

What is the Wolverine peptide blend?

Wolverine is a pre-mixed research formulation combining two peptides, BPC-157 and TB-500, in one lyophilized preparation. It is studied in recovery and tissue-repair contexts because the two peptides are thought to act on complementary pathways. It is not a single novel compound and is not approved for human use.

Why are BPC-157 and TB-500 combined in one blend?

Researchers pair them because preclinical work frames their mechanisms as complementary: BPC-157 is associated with angiogenesis and growth-factor signaling, while TB-500 is associated with actin regulation and cell migration. The idea that combining them produces synergy is a hypothesis from laboratory models, not a proven human outcome.

Is the Wolverine blend more effective than BPC-157 or TB-500 alone?

There is no controlled human evidence establishing that the blend is more effective than either peptide individually — the rationale for combining them comes from preclinical pathway complementarity, not comparative clinical trials. Combining two research peptides also increases the overall uncertainty rather than reducing it. Any efficacy claim remains unproven in humans.

Is the Wolverine blend approved for human use?

No. Both components, BPC-157 and TB-500, are unapproved for human use by regulatory authorities and are prohibited in sport under anti-doping rules. The blend is sold strictly for research and educational purposes only, not for human consumption.

What research supports the Wolverine blend?

The blend inherits the preclinical evidence base of its two components, which consists almost entirely of cell-culture and animal studies of BPC-157 and TB-500 separately. There are essentially no completed, controlled human efficacy trials of either peptide or of the combination, so findings should be treated as laboratory observations rather than established human effects.

Source Wolverine at Purgo Labs

≥99% purity, third-party COA verification, and same-day fulfillment.

Shop Wolverine at Purgo Labs ↗
Use code FITNESS for 15% off

Related compounds

For research and educational purposes only. Wolverine is not approved for human use by any regulatory authority, and nothing on this page constitutes medical advice, diagnosis, or treatment. Research findings referenced here are predominantly preclinical.